Switch to:
More From Other Websites
ETFs with exposure to Keryx Biopharmaceuticals, Inc. : December 5, 2016 Dec 05 2016
ETFs with exposure to Keryx Biopharmaceuticals, Inc. : November 23, 2016 Nov 23 2016
Keryx Biopharmaceuticals, Inc. :KERX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 21,... Nov 21 2016
Keryx Biopharmaceuticals Announces Case Study Data of Auryxia® Presented at ASN’s Kidney Week Nov 18 2016
Keryx Biopharmaceuticals Announces Case Study Data of Auryxia® Presented at ASN’s Kidney Week Nov 18 2016
Keryx (KERX) Stock Up on Positive Phase III Auryxia Data Nov 18 2016
KERYX BIOPHARMACEUTICALS INC Financials Nov 17 2016
Keryx Biopharmaceuticals Announces Multiple Scientific Presentations of Phase 3 Trial Results of... Nov 17 2016
Keryx (KERX) Q3 Loss Wider than Expected, Restores Supply Nov 10 2016
​FDA action helps Keryx move past drug supply snafu Nov 10 2016
KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events Nov 09 2016
Edited Transcript of KERX earnings conference call or presentation 9-Nov-16 1:00pm GMT Nov 09 2016
ETF’s with exposure to Keryx Biopharmaceuticals, Inc. : November 9, 2016 Nov 09 2016
Keryx Biopharma upgraded by Maxim Group Nov 09 2016
Keryx Biopharmaceuticals Announces U.S. FDA Approval of Second Contract Manufacturer for Auryxia®... Nov 09 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK